G
Ghislaine Le Gall-Reculé
Researcher at ANSES
Publications - 27
Citations - 1145
Ghislaine Le Gall-Reculé is an academic researcher from ANSES. The author has contributed to research in topics: Lagovirus & Rabbit haemorrhagic disease. The author has an hindex of 16, co-authored 26 publications receiving 967 citations. Previous affiliations of Ghislaine Le Gall-Reculé include European University of Brittany.
Papers
More filters
Journal ArticleDOI
Emergence of a new lagovirus related to Rabbit Haemorrhagic Disease Virus
Ghislaine Le Gall-Reculé,Ghislaine Le Gall-Reculé,Antonio Lavazza,Stéphane Marchandeau,Stéphane Bertagnoli,F. Zwingelstein,F. Zwingelstein,Patrizia Cavadini,Nicola Martinelli,Guerino Lombardi,Jean-Luc Guérin,Evelyne Lemaitre,Evelyne Lemaitre,Anouk Decors,Samuel Boucher,Bernadette Le Normand,Lorenzo Capucci +16 more
TL;DR: Experimental results show that the disease differs from RHD in terms of disease duration, mortality rates, higher occurrence of subacute/chronic forms and that partial cross-protection occurs between RHDV and the new R HDV variant, designated RHDVs2, which supports the hypothesis that RHDv2 is a new member of the Lagovirus genus.
Journal ArticleDOI
Proposal for a unified classification system and nomenclature of lagoviruses.
Jacques Le Pendu,Joana Abrantes,Stéphane Bertagnoli,Jean Sébastien Guitton,Ghislaine Le Gall-Reculé,Ana M. Lopes,Stéphane Marchandeau,Fernando Alda,Tereza Almeida,Alves Paulo Célio,Alves Paulo Célio,Juan Bárcena,Galina Burmakina,Esther Blanco,Carlos Calvete,Patrizia Cavadini,Brian Cooke,Kevin P. Dalton,Miguel Delibes Mateos,Wiesław Deptuła,John-Sebastian Eden,Fang Wang,Catarina Ferreira,Catarina Ferreira,Paula G. Ferreira,Pilar Foronda,David Gonçalves,Dolores Gavier-Widén,Robin Hall,Beata Hukowska-Szematowicz,Peter J. Kerr,John Kovaliski,Antonio Lavazza,Jackie E. Mahar,Jackie E. Mahar,Alexander Malogolovkin,Raquel M. Marques,Sara Marques,Aarón Martin-Alonso,Pedro Monterroso,Sacramento Moreno,Greg Mutze,Aleksija Neimanis,Paulina Niedzwiedzka-Rystwej,David Peacock,Francisco Parra,Mara Rocchi,Carlos Rouco,Nathalie Ruvoën-Clouet,Eliane Silva,Diogo Silvério,Tanja Strive,Gertrudes Thompson,Beata Tokarz-Deptuła,Pedro J. Esteves +54 more
TL;DR: It is proposed that an international working group could coordinate the nomenclature of lagoviruses and any proposals for revision and be divided into two genogroups that correspond to RHDV- and EBHSV-related viruses, respectively.
Journal ArticleDOI
The new French 2010 Rabbit Hemorrhagic Disease Virus causes an RHD-like disease in the Sardinian Cape hare (Lepus capensis mediterraneus).
Giantonella Puggioni,Patrizia Cavadini,Caterina Maestrale,Rosario Scivoli,Giuliana Botti,Ciriaco Ligios,Ghislaine Le Gall-Reculé,Ghislaine Le Gall-Reculé,Antonio Lavazza,Lorenzo Capucci +9 more
TL;DR: The identification of RHDV2 as the cause in Sardinia of several outbreaks of acute hepatitis in rabbits and Cape hare is reported, the first account of a lagovirus that causes fatal hepatitis in both rabbits and hares.
Journal ArticleDOI
Histo-blood group antigens act as attachment factors of rabbit hemorrhagic disease virus infection in a virus strain-dependent manner.
Kristina Nyström,Ghislaine Le Gall-Reculé,Paola Grassi,Joana Abrantes,Nathalie Ruvoën-Clouet,Béatrice Le Moullac-Vaidye,Ana M. Lopes,Pedro J. Esteves,Tanja Strive,Tanja Strive,Stéphane Marchandeau,Anne Dell,Stuart M. Haslam,Jacques Le Pendu +13 more
TL;DR: Binding was observed to blood group B, A and H type 2 epitopes in a strain-dependent manner with slight differences in specificity for A, B or H epitopes allowing RHDV strains to preferentially recognize different subgroups of animals.
Journal ArticleDOI
Current strategies for subunit and genetic viral veterinary vaccine development.
Alejandro Brun,Juan Bárcena,Esther Blanco,Belén Borrego,Daniel Dory,José M. Escribano,Ghislaine Le Gall-Reculé,Javier Ortego,Linda K. Dixon +8 more
TL;DR: This paper reviews several antigen production and delivery strategies other than those based on the use of live viral vectors, including genetic and protein subunit vaccines as well as alternative production systems.